carotegrast methyl
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started Jun 6, 2018 (NCT03531892)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- carotegrast methyl
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06897150 | Phase 4 | Jun 1, 2022 | Yokkaichi Hazu Medical Center |
| NCT03531892 | Phase 3 | Jun 6, 2018 | EA Pharma Co., Ltd., Kissei Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EA Pharma Co., Ltd. | For profit | 1 | 1 | 1 | 2018 |
| Kissei Pharmaceuticals | For profit | 1 | 0 | 1 | 2018 |
| Yokkaichi Hazu Medical Center | Academic/Hospital | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1